Allied Investment Advisors LLC Grows Holdings in Procter & Gamble Company (The) $PG

Allied Investment Advisors LLC boosted its stake in shares of Procter & Gamble Company (The) (NYSE:PG) by 1.1% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 66,623 shares of the company’s stock after purchasing an additional 725 shares during the quarter. Procter & Gamble comprises 1.9% of Allied Investment Advisors LLC’s holdings, making the stock its 25th largest holding. Allied Investment Advisors LLC’s holdings in Procter & Gamble were worth $10,614,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also recently modified their holdings of PG. Kingstone Capital Partners Texas LLC lifted its holdings in shares of Procter & Gamble by 655,209.0% during the second quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company’s stock worth $11,832,680,000 after purchasing an additional 76,017,350 shares during the period. Nuveen LLC acquired a new stake in shares of Procter & Gamble during the first quarter worth about $1,954,941,000. Price T Rowe Associates Inc. MD raised its position in Procter & Gamble by 13.0% during the first quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company’s stock valued at $3,660,737,000 after acquiring an additional 2,466,308 shares in the last quarter. Invesco Ltd. boosted its position in Procter & Gamble by 19.8% in the 1st quarter. Invesco Ltd. now owns 13,493,604 shares of the company’s stock worth $2,299,580,000 after purchasing an additional 2,228,151 shares in the last quarter. Finally, Valeo Financial Advisors LLC grew its stake in shares of Procter & Gamble by 1,875.5% during the 2nd quarter. Valeo Financial Advisors LLC now owns 1,763,404 shares of the company’s stock worth $280,946,000 after purchasing an additional 1,674,139 shares during the period. 65.77% of the stock is owned by hedge funds and other institutional investors.

Procter & Gamble Stock Performance

Shares of NYSE PG opened at $152.62 on Friday. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.49 and a current ratio of 0.70. The firm has a market cap of $357.21 billion, a price-to-earnings ratio of 23.44, a P/E/G ratio of 4.04 and a beta of 0.36. The business’s 50-day simple moving average is $154.66 and its 200-day simple moving average is $158.41. Procter & Gamble Company has a 52 week low of $146.96 and a 52 week high of $180.43.

Procter & Gamble (NYSE:PG) last issued its quarterly earnings data on Friday, October 24th. The company reported $1.99 EPS for the quarter, beating analysts’ consensus estimates of $1.90 by $0.09. The business had revenue of $22.39 billion for the quarter, compared to analyst estimates of $22.23 billion. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The firm’s revenue for the quarter was up 3.0% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.93 EPS. Procter & Gamble has set its FY 2026 guidance at 6.830-7.100 EPS. As a group, equities research analysts expect that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.

Procter & Gamble Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, November 17th. Shareholders of record on Friday, October 24th will be issued a $1.0568 dividend. The ex-dividend date of this dividend is Friday, October 24th. This represents a $4.23 dividend on an annualized basis and a yield of 2.8%. Procter & Gamble’s dividend payout ratio (DPR) is 64.98%.

Insider Transactions at Procter & Gamble

In other news, insider Balaji Purushothaman sold 490 shares of Procter & Gamble stock in a transaction that occurred on Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total transaction of $74,592.70. Following the sale, the insider owned 12,616 shares of the company’s stock, valued at approximately $1,920,533.68. This trade represents a 3.74% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, COO Shailesh Jejurikar sold 3,986 shares of the firm’s stock in a transaction that occurred on Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total value of $606,788.78. Following the transaction, the chief operating officer owned 46,899 shares of the company’s stock, valued at $7,139,434.77. This trade represents a 7.83% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 149,763 shares of company stock worth $23,421,279. Insiders own 0.20% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on PG shares. Wells Fargo & Company cut their target price on shares of Procter & Gamble from $173.00 to $170.00 and set an “overweight” rating for the company in a report on Thursday, September 25th. Evercore ISI reaffirmed an “in-line” rating and set a $170.00 target price (down previously from $190.00) on shares of Procter & Gamble in a research note on Monday, July 14th. BNP Paribas reaffirmed an “outperform” rating and set a $177.00 target price on shares of Procter & Gamble in a research note on Friday, August 15th. Berenberg Bank lifted their target price on shares of Procter & Gamble from $152.00 to $154.00 and gave the stock a “hold” rating in a research note on Wednesday, September 17th. Finally, UBS Group lowered their price target on shares of Procter & Gamble from $180.00 to $176.00 and set a “buy” rating on the stock in a research report on Wednesday, October 8th. Eleven investment analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, Procter & Gamble currently has a consensus rating of “Moderate Buy” and an average target price of $171.68.

Procter & Gamble Profile

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.